Log in to save to my catalogue

Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease

Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6cd67cc82091480f9e692f0782646033

Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease

About this item

Full title

Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease

Publisher

London, England: SAGE Publications

Journal title

Therapeutic Advances in Neurological Disorders, 2019, Vol.12, p.1756286419888819-1756286419888819

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Alzheimer’s disease (AD) is the most common neurodegenerative disease and its diagnosis has classically been based on clinical symptoms. Recently, a biological rather than a syndromic definition of the disease has been proposed that is based on biomarkers that reflect neuropathological changes. In AD, there are two main biomarker categories, namely...

Alternative Titles

Full title

Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6cd67cc82091480f9e692f0782646033

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6cd67cc82091480f9e692f0782646033

Other Identifiers

ISSN

1756-2864,1756-2856

E-ISSN

1756-2864

DOI

10.1177/1756286419888819

How to access this item